数字化转型成功：Robling Medical如何借助IQVIA SmartSolve® eQMS革新质量管理

Table of contentsExecutive summary1Key objectives1Company background1Contract manufacturing industry dynamics2Regulatory environment evolution2The challenge: Paper-based limitations3Operational pain points3Strategic implications4Solution selection: Partnership-driven evaluation5Comprehensive vendor assessment5IQVIA SmartSolve: The strategic choice5Implementation strategy: Phased approach for success6Critical success factors6Results and expected benefits7Quantified operational improvements7Strategic benefits7Lessons learned and best practices8Vendor selection insights8Implementation best practices8Future outlook: AI and advanced analytics8Current positioning8Potential applications8Risk management approach8Elements for success9Strategic considerations9Operational insights9Conclusion10 Executive summary Robling Medical, a leading contract manufacturerin the medical device industry, is in the process oftransforming their paper-based quality managementprocesses through strategic implementation of IQVIA’s Key objectives: • Estimated expectation of 20-30% reduction in manual • Estimated expectation 15-25% improvement in auditpreparation efficiency with electronic record access in accommodate varying customer requirements while • Elimination of weeks-long data retrieval cycles,reducing analysis time from weeks to minutes The organization’s client portfolio spans multipledevice classifications, from Class I (low risk) devicesrequiring basic quality controls to Class III (high risk)devices demanding comprehensive risk managementand validation protocols. Clients also include those inthe pharmaceutical industry that use medical device •Streamline customer approval workflows eliminatingemail/scan cycles and improved customer confidence • Foundation established for future AI and analyticscapabilities through standardized data architecture in Company background Robling Medical operates as a leading contractmanufacturer serving multiple Original Equipment Contract manufacturing Regulatory environment • The global medical device regulatory landscapecontinues to evolve rapidly, with new requirementsemerging across global markets.EU MDR and IVDRimplementationhas created significant compliance The contract manufacturing sector faces uniqueoperational challenges that distinguish it from traditional • Regulatory responsibility sharingcreatescomplex compliance frameworks where OEMswork with Robling Medical to fulfill their globalregulatory and quality compliance activities. This •ISO 13485 certification maintenancerequirescontinuous improvement and system effectivenessdemonstration, making electronic quality management • Customer relationship managementin contractmanufacturing involves coordinating multiple OEMpartnerships simultaneously, each with distinctapproval processes, quality requirements and •Competitive differentiationincreasingly dependson quality system capabilities as customers evaluatecontract manufacturers based on their ability to The challenge: Paper-based limitations Operational pain points Robling Medical’s paper-based quality management system is regularly audited by customers and regulatoryagencies, including the U.S. FDA, and is certified to these global requirements. Maintaining this high level ofcompliance with paper-based activities relies on a significant amount of labor-intensive cross-referencing of quality Modern medical device companies increasingly expectreal-time visibility into quality metrics, rapid issueresolution and sophisticated analytics capabilities from Strategic implications The paper-based approach created multiple barriersthat limited Robling Medical’s competitive positioning,operational effectiveness and growth potential. In an The inability to integrate with customer systems orprovide electronic data exchange capabilities alsocreated technology integration barriers. This limitation Scalability presented a significant challenge as addingnew customers or expanding existing relationshipsrequired proportional increases in administrative contract manufacturing customers. Along withregulatory responsibility management, SmartSolveis distinguished from general-purpose quality Solution selection:Partnership-driven evaluation Comprehensive vendor assessment Robling Medical evaluated multiple enterprise qualitymanagement platforms, the evaluation process • Regulatory intelligence:Built-in compliancemonitoring and proactive regulatory updates ensure IQVIA SmartSolve: The strategic choice Robling Medical selected IQVIA SmartSolve based onseveral compelling factors: • Partnership-driven support:The selection decisionreflected Robling’s philosophy that relationship qualityis key to determining long-term implementationsuccess. IQVIA’s accessible team structure of dedicatedprofessionals ensures consistent implementation • Proven track record:Robling’s 8–10-year relationshipwith key IQVIA personnel has demonstrated reliableexecution. The seamless transition from cus